Parlux
This article was originally published in The Rose Sheet
Executive Summary
Revenues for the fiscal year ended March 31, 2005 are expected to increase 26% to approximately $100 mil., the Fort Lauderdale, Fla. firm reports May 2. Earnings per share are projected to be up around 60% to $.99-$1.01, Parlux says. Results were boosted by the strength of the Perry Ellis fragrance brand, as well as the Paris Hilton range, firm notes. The international rollout of Paris Hilton has been "extremely successful," and is "paving the road for the Guess launch," which is slated for this year (1"The Rose Sheet" Nov. 10, 2003, p. 4). Final results for Q4 and the full fiscal year will be announced in June...
You may also be interested in...
Guess? Fragrances Will Be Reintroduced By Parlux In 2005
Fragrance marketer Parlux will launch Guess? scents in over 1,000 U.S. specialty store doors and all freestanding Guess boutiques in early 2005, Parlux VP Marketing Kathleen Galvin said
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.